Bhumyamalaki (Phyllanthus niruri)
Bhumyamalaki (Phyllanthus niruri) contains phyllanthin and hypophyllanthin, lignans that protect liver cells from oxidative damage and support hepatic detoxification pathways. The herb demonstrates significant hepatoprotective effects by inhibiting lipid peroxidation and reducing elevated liver enzymes.
Origin & History
Bhumyamalaki, also known as Phyllanthus niruri, is a small herb found in tropical regions. It is commonly used in traditional medicine for its hepatoprotective properties.
Historical & Cultural Context
Traditionally, Bhumyamalaki has been used in Ayurveda for its liver-protective effects and as a remedy for jaundice and other liver-related ailments.
Health Benefits
- Supports liver health by promoting detoxification, reducing liver enzyme levels by up to 40% in clinical studies. - Enhances kidney function by preventing stone formation, acting as a natural diuretic. - Boosts immune system by stimulating macrophage activity, enhancing the body's defense mechanisms. - Reduces inflammation by inhibiting pro-inflammatory pathways, which can help alleviate chronic pain conditions. - Promotes skin health by reducing oxidative stress, leading to clearer, more radiant skin. - Aids in digestion by enhancing bile production, improving nutrient absorption and reducing digestive discomfort. - Provides antiviral properties by inhibiting viral replication, offering protection against common viral infections.
How It Works
Bhumyamalaki's primary bioactive compounds phyllanthin and hypophyllanthin inhibit hepatic cytochrome P450 enzymes while enhancing glutathione S-transferase activity, promoting Phase II detoxification. The herb's geraniin and corilagin tannins exhibit antioxidant properties by scavenging free radicals and reducing lipid peroxidation in liver tissue. Additionally, the plant's alkaloids modulate immune function by activating macrophage phagocytic activity and stimulating cytokine production.
Scientific Research
Studies on Bhumyamalaki suggest its efficacy in supporting liver health and treating viral infections. Some research includes animal studies and preliminary human trials.
Clinical Summary
Human trials involving 120-180 participants with hepatitis B showed Bhumyamalaki reduced ALT and AST liver enzymes by 35-40% over 30 days compared to placebo. Smaller studies (n=40-60) demonstrated significant reduction in kidney stone recurrence rates and improved urinary citrate levels. However, most clinical evidence comes from short-term studies with limited sample sizes, requiring larger long-term trials to confirm sustained benefits. The hepatoprotective effects appear most pronounced in acute liver stress rather than chronic conditions.
Nutritional Profile
Bhumyamalaki (Phyllanthus niruri) is a medicinal herb with a complex phytochemical profile rather than a conventional macronutrient-rich food source. Macronutrient composition per 100g dried herb: crude protein approximately 10-14g, crude fiber 15-20g, carbohydrates approximately 40-50g, crude fat 2-4g, moisture content 8-12%. Key bioactive lignans include phyllanthin (0.5-1.2% dry weight) and hypophyllanthin (0.3-0.8% dry weight), which are primary hepatoprotective agents. Flavonoids present include quercetin, rutin, and astragalin at concentrations of 0.8-2.5% total flavonoid content. Tannins, particularly geraniin and corilagin (ellagitannins), are found at 4-8% dry weight and contribute to antiviral and antioxidant activity. Alkaloids including phyllantidine and phyllantine are present at trace levels (0.01-0.05%). Triterpenoids such as phyllantol and cymene occur at approximately 0.1-0.5%. Mineral content includes potassium (800-1200mg/100g), calcium (200-400mg/100g), magnesium (150-250mg/100g), iron (15-25mg/100g), and zinc (3-6mg/100g). Vitamin C is present at approximately 25-60mg/100g in fresh plant material, significantly reduced upon drying. Gallic acid and ellagic acid are present at 1-3% dry weight. Phenolic acids including caffeic and ferulic acid contribute to total polyphenol content of 8-15% dry weight. Bioavailability note: lignans and ellagitannins show moderate oral bioavailability; absorption of phyllanthin is enhanced with lipid co-administration due to its lipophilic nature; standardized extracts typically normalized to 0.5-1% phyllanthin content for therapeutic consistency.
Preparation & Dosage
The typical dosage of Bhumyamalaki is 500-1000 mg per day. Consult a healthcare provider before use.
Synergy & Pairings
Turmeric, Milk Thistle, Dandelion Root, Amla
Safety & Interactions
Bhumyamalaki is generally well-tolerated with mild gastrointestinal upset reported in 5-8% of users at doses above 1000mg daily. The herb may enhance the effects of antidiabetic medications by lowering blood glucose, requiring monitoring in diabetic patients. Due to its diuretic properties, it may increase lithium retention and should be avoided with lithium therapy. Pregnancy and breastfeeding safety data is insufficient, warranting avoidance during these periods.